156 related articles for article (PubMed ID: 26362315)
1. Optimal detection of hypothyroidism in early stage laryngeal cancer treated with radiotherapy.
Mulholland GB; Zhang H; Nguyen NT; Tkacyzk N; Seikaly H; O'Connell D; Biron VL; Harris JR
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):34. PubMed ID: 26362315
[TBL] [Abstract][Full Text] [Related]
2. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
[TBL] [Abstract][Full Text] [Related]
3. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
4. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
5. Thyroid function should be monitored following radiotherapy to the low neck.
Garcia-Serra A; Amdur RJ; Morris CG; Mazzaferri E; Mendenhall WM
Am J Clin Oncol; 2005 Jun; 28(3):255-8. PubMed ID: 15923797
[TBL] [Abstract][Full Text] [Related]
6. Thyroid dysfunction in patients treated with radiotherapy for neck.
Koc M; Capoglu I
Am J Clin Oncol; 2009 Apr; 32(2):150-3. PubMed ID: 19307948
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
8. [Treatment and prognosis of stage III-IV laryngeal squamous cell carcinoma].
Tian WD; Zeng ZY; Chen FJ; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2006 Jan; 25(1):80-4. PubMed ID: 16405756
[TBL] [Abstract][Full Text] [Related]
9. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
11. [Hypothyroidism in patients treated for laryngeal cancer: preliminary results].
Romero A; Esteban F; Delgado M; Solanellas J; Soldado L; Fernández I; Hidalgo J; Rodríguez Adrados F
Acta Otorrinolaringol Esp; 1999 Apr; 50(3):205-10. PubMed ID: 10362864
[TBL] [Abstract][Full Text] [Related]
12. Thyroid diseases as a sequelae following treatment of head and neck cancer.
Banipal R; Mahajan MK; Uppal B; John M
Indian J Cancer; 2011; 48(2):194-8. PubMed ID: 21768665
[TBL] [Abstract][Full Text] [Related]
13. The incidence of thyroid dysfunction following radiotherapy for early stage carcinoma of the larynx.
Kumar S; Moorthy R; Dhanasekar G; Thompson S; Griffiths H
Eur Arch Otorhinolaryngol; 2011 Oct; 268(10):1519-22. PubMed ID: 21328003
[TBL] [Abstract][Full Text] [Related]
14. Hypothyroidism when the thyroid is included only in the low neck field during head and neck radiotherapy.
Norris AA; Amdur RJ; Morris CG; Mendenhall WM
Am J Clin Oncol; 2006 Oct; 29(5):442-5. PubMed ID: 17023776
[TBL] [Abstract][Full Text] [Related]
15. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck.
Colevas AD; Read R; Thornhill J; Adak S; Tishler R; Busse P; Li Y; Posner M
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):599-604. PubMed ID: 11597798
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism after radiotherapy for nasopharyngeal cancer patients.
Wu YH; Wang HM; Chen HH; Lin CY; Chen EY; Fan KH; Huang SF; Chen IH; Liao CT; Cheng AJ; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1133-9. PubMed ID: 19596170
[TBL] [Abstract][Full Text] [Related]
17. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
18. Predictors of local failure in early laryngeal cancer.
Lohynska R; Slavicek A; Bahanan A; Novakova P
Neoplasma; 2005; 52(6):483-8. PubMed ID: 16284693
[TBL] [Abstract][Full Text] [Related]
19. High mTOR expression is associated with a worse oncological outcome in laryngeal carcinoma treated with postoperative radiotherapy: a pilot study.
Lionello M; Blandamura S; Loreggian L; Ottaviano G; Giacomelli L; Marchese-Ragona R; Velardita C; Staffieri A; Marioni G
J Oral Pathol Med; 2012 Feb; 41(2):136-40. PubMed ID: 21943204
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism after radiotherapy for laryngeal cancer.
Kumpulainen EJ; Hirvikoski PP; Virtaniemi JA; Johansson RT; Simonen PM; Terävä MT; Asikainen RJ; Nykänen KJ; Kosma V
Radiother Oncol; 2000 Oct; 57(1):97-101. PubMed ID: 11033194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
